介入治疗在子宫肌瘤合并继发性贫血中的应用  

Interventional treatment in uterine myoma combined with secondary anemia

作　　者：余莉萍[1] 陈春林[1] 吕军[1] 刘萍[1] 马奔[1] 陈淑贤[1] 刘佩鸣[1] 

机构地区：[1]广州市第一人民医院妇产科,510180

出　　处：《中国实用妇科与产科杂志》2002年第9期551-552,共2页Chinese Journal of Practical Gynecology and Obstetrics

摘　　要：目的　研究选择性子宫动脉栓塞术 (UAE)治疗在子宫肌瘤合并继发性贫血中的临床效果。方法　采用Seldingers方法作选择性子宫动脉栓塞 ,治疗 4 5例合并继发性贫血的子宫肌瘤患者。结果　随访 18～ 2 4个月。血红蛋白值 (Hb)由术前的 (84 4± 2 1 6 ) g/L恢复至 (12 0 6± 13 1)g/L。月经周期无改变 ,经期缩短 ,月经量减少至术前的 (5 0 6± 18 2 ) %。子宫及肌瘤体积均有不同程度的缩小。结论　UAE治疗子宫肌瘤合并继发性贫血患者 ,能有效地减少月经量 ,缩小瘤体 ,迅速纠正贫血 。Objective To assess the clinical effects of selected uterine arterial embolization (UAE) in uterine myoma combined with secondary anemia.Methods Selected UAE was performed by Seldinger's technique in 45 patients,who had uterine myoma combined with secondary anemia.The 18～24 months effectiveness in all patients after treatment were investigated.Results Hemoglobin (Hb) returned from (84 4±21 6)g/L before operation to( 120 6±13 1)g/L.Catamenia shortened and menorrhagia reduced to(50 6±18 2)% with periods unchanged.The size of uterus and myoma decreased at different degrees.Conclusion UAE is a confirmed method for the treatment of uterine myoma combined with secondary anemia.It can decrease the menorrhagia amount,reduce the myoma size and redress anemia rapidly.

关 键 词：介入治疗 子宫肌瘤 继发性贫血 子宫动脉栓塞 血红蛋白 

分 类 号：R737.33[医药卫生—肿瘤] R556[医药卫生—临床医学]